Gregory Berk Gt Biopharma, Inc. (GTBP) insider trading activity
Gregory Berk is Pres. of R&D, CMO of GT Biopharma, Inc.. Currently has a direct ownership of 278,058 shares of GTBP, which is worth approximately $781,342. The most recent transaction as insider was on Feb 16, 2021, when has been sold 278,058 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
278K
0%
3M change
0%
12M change
Total Value Held
$781,342
GB
Gregory Berk
Pres. of R&D, CMO
Brisbane, CA